
    
      Evaluate the potential of DSXS topical product to suppress HPA axis function in patients with
      moderate to severe scalp psoriasis. Evaluate the efficacy parameters and adverse event (AE)
      profiles of DSXS topical product administered to patients with moderate to severe scalp
      psoriasis.
    
  